Free Trial
Want deep insights into your competitors & competitive landscape? Try Patsnap Eureka!

Top 10 Key Players companies in Multiple sklerose
by Highest Patent Value in the Switzerland in 2022

The Multiple sklerose top 10 is Discovery PatSnap’ annual ranking of the top 10 Highest Patent Value Multiple sklerose Key Players in the Switzerland. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2022, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.
Multiple sclerosis is a progressive autoimmune disease that damages the insulating covers of brain cells. Depending on the brain region affected, it causes symptoms such as physical and mental dysfunction, fatigue, pain, depression, and anxiety [R+].
#
Company Name
Region
Tech Topics
Total
1
Avg patent value: 9.60 M
2
Antibody,Medicine,Health care,
...[+2]
Avg patent value: 6.86 M
3
Multiple sclerosis,Health care,Pharmacy and Therapeutics,
...[+2]
Avg patent value: 6.49 M
4
Avg patent value: 6.49 M
5
Avg patent value: 5.45 M
6
Avg patent value: 3.77 M
7
Avg patent value: 3.64 M
8
Healthcare system,Medicine
Avg patent value: 3.56 M
9
Medicine,Health care,Drug,
...[+2]
Avg patent value: 1.96 M
10
Medicine,Health care,Cerebral vasospasm,
...[+2]
Avg patent value: 1.96 M
Page generation time: Jul 23 2025